(Source: ImmunoCellular Therapeutics Ltd) LOS ANGELES, Nov. 12, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ('ImmunoCellular') (NYSE MKT: IMUC) today announced it has entered into a sponsored research agreement with Dr. Cassian Yee at the University of Texas MD Anderson Cancer Center. Dr. Yee is an internationally recognized researcher and leading expert in identifying and isolating cytotoxic T cells. He serves as Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, as well as Professor, Department of Immunology, Division of Cancer Medicine, and Director, Solid Tumor Cell Therapy, Center for Cancer Immunology Research, at MD Anderson. Dr. Yee will focus...
↧